Home LiteratureArticle Details
PMID: 12847141 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Cross-presentation of disialoganglioside GD3 to natural killer T cells.

The Journal of experimental medicine ·Vol. 198 ·No. 1 ·2003-07-07 ·Pages 173-81

Wu DY, Segal NH, Sidobre S, Kronenberg M, Chapman PB

Abstract

GD3, a ganglioside expressed on human melanoma, can be recognized by the humoral immune system. In this paper, we demonstrate that immunizing mice with the human melanoma cell line SK-MEL-28 (GD3+ GM2- CD1-) or with syngeneic APCs loaded with GD3 can induce a GD3-reactive natural killer T (NKT) cell response. GD3-reactive NKT cells were detected among splenocytes of immunized mice at frequencies of approximately 1:2000 both by ELISPOT and GD3-loaded mouse CD1d tetramer analysis. GD3-reactive NKT cells did not react with GM2, a closely related ganglioside, and were not detectable in unimmunized mice. GD3-reactive NKT cells initially produced IL-4 and IFN-gamma followed by IL-10. They were CD1d restricted in that reactivity was abrogated when APCs were blocked with anti-CD1d monoclonal antibody before being loaded with GD3 or when APCs from CD1d knockout mice were used. Because SK-MEL-28 does not express any isoform of human CD1, GD3 must be cross-presented by murine APCs in vivo. This is the first analysis of a natural ligand for mouse NKT cells and the first definitive paper of cross-presentation to NKT cells. This could be a mechanism for NKT cell recognition of tumor gangliosides in CD1- tumors.

MeSH Terms
Amino Acid Sequence Animals Antigen Presentation Antigen-Presenting Cells/physiology Antigens, CD1/physiology Antigens, CD1d Cytokines/biosynthesis Female Galactosylceramides/pharmacology Gangliosides/immunology Humans Immunization Killer Cells, Natural/immunology Mice Mice, Inbred C57BL Molecular Sequence Data
Chemicals
Antigens, CD1 Antigens, CD1d CD1D protein, human Cytokines Galactosylceramides Gangliosides ganglioside, GD3
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Wu Dianna Y
Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA.
Segal Neil H
Sidobre Stephane
Kronenberg Mitchell
Chapman Paul B
References (33)
33 references, click to expand
  1. Classification of clear-cell sarcoma as a subtype of melanoma by genomic profiling.
    J Clin Oncol. 2003 May 1;21(9):1775-81 PMID: 12721254
  2. CD1d-restricted help to B cells by human invariant natural killer T lymphocytes.
    J Exp Med. 2003 Apr 21;197(8):1051-7 PMID: 12695492
  3. Phase I trial of a mouse monoclonal antibody against GD3 ganglioside in patients with melanoma: induction of inflammatory responses at tumor sites.
    J Clin Oncol. 1988 Oct;6(10):1636-48 PMID: 3171629
  4. Light chain variants of an IgG3 anti-GD3 monoclonal antibody and the relationship among avidity, effector functions, tumor targeting, and antitumor activity.
    Cancer Res. 1990 Mar 1;50(5):1503-9 PMID: 2105840
  5. Antibody response to immunization with ganglioside GD3 and GD3 congeners (lactones, amide and gangliosidol) in patients with malignant melanoma.
    Int J Cancer. 1991 May 30;48(3):379-85 PMID: 2040532
  6. Induction of IgG antibodies against GD3 ganglioside in rabbits by an anti-idiotypic monoclonal antibody.
    J Clin Invest. 1991 Jul;88(1):186-92 PMID: 2056117
  7. Immunosuppression by human gangliosides: I. Relationship of carbohydrate structure to the inhibition of T cell responses.
    Biochim Biophys Acta. 1992 Apr 23;1125(2):180-8 PMID: 1571361
  8. Glycosylation pathways in the biosynthesis of gangliosides in melanoma and neuroblastoma cells: relative glycosyltransferase levels determine ganglioside patterns.
    Cancer Res. 1992 Oct 15;52(20):5725-31 PMID: 1394196
  9. Immunocytochemical study on internalization of anti-carbohydrate monoclonal antibodies.
    Anticancer Res. 1993 Nov-Dec;13(6A):2207-12 PMID: 8297135
  10. An invariant T cell receptor alpha chain is used by a unique subset of major histocompatibility complex class I-specific CD4+ and CD4-8- T cells in mice and humans.
    J Exp Med. 1994 Sep 1;180(3):1097-106 PMID: 7520467
  11. CD1 recognition by mouse NK1+ T lymphocytes.
    Science. 1995 May 12;268(5212):863-5 PMID: 7538697
  12. Characterization of an Ig VH idiotope that results in specific homophilic binding and increased avidity for antigen.
    J Immunol. 1996 Aug 15;157(4):1582-8 PMID: 8759742
  13. A single T cell receptor recognizes structurally distinct MHC/peptide complexes with high specificity.
    J Exp Med. 1996 Sep 1;184(3):1017-26 PMID: 9064319
  14. Mouse CD1-specific NK1 T cells: development, specificity, and function.
    Annu Rev Immunol. 1997;15:535-62 PMID: 9143699
  15. Crystal structure of mouse CD1: An MHC-like fold with a large hydrophobic binding groove.
    Science. 1997 Jul 18;277(5324):339-45 PMID: 9219685
  16. Structural requirements for glycolipid antigen recognition by CD1b-restricted T cells.
    Science. 1997 Oct 10;278(5336):283-6 PMID: 9323206
  17. CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides.
    Science. 1997 Nov 28;278(5343):1626-9 PMID: 9374463
  18. Anti-melanoma effects of R24, a monoclonal antibody against GD3 ganglioside.
    Melanoma Res. 1997 Aug;7 Suppl 2:S155-62 PMID: 9578432
  19. The CD1 family of lipid antigen-presenting molecules.
    Immunol Today. 1998 Aug;19(8):362-8 PMID: 9709504
  20. Selective ability of mouse CD1 to present glycolipids: alpha-galactosylceramide specifically stimulates V alpha 14+ NK T lymphocytes.
    J Immunol. 1998 Oct 1;161(7):3271-81 PMID: 9759842
  21. CD1d-mediated recognition of an alpha-galactosylceramide by natural killer T cells is highly conserved through mammalian evolution.
    J Exp Med. 1998 Oct 19;188(8):1521-8 PMID: 9782129
  22. Immunization of melanoma patients with BEC2 anti-idiotypic monoclonal antibody that mimics GD3 ganglioside: enhanced immunogenicity when combined with adjuvant.
    Clin Cancer Res. 1996 Apr;2(4):679-86 PMID: 9816218
  23. Self glycolipids as T-cell autoantigens.
    Eur J Immunol. 1999 May;29(5):1667-75 PMID: 10359121
  24. The CD1 system: antigen-presenting molecules for T cell recognition of lipids and glycolipids.
    Annu Rev Immunol. 1999;17:297-329 PMID: 10358761
  25. Induction of antibodies against GD3 ganglioside in melanoma patients by vaccination with GD3-lactone-KLH conjugate plus immunological adjuvant QS-21.
    Int J Cancer. 2000 Mar 1;85(5):659-66 PMID: 10699946
  26. In vivo identification of glycolipid antigen-specific T cells using fluorescent CD1d tetramers.
    J Exp Med. 2000 Jun 5;191(11):1895-903 PMID: 10839805
  27. The monoclonal antibody TER-119 recognizes a molecule associated with glycophorin A and specifically marks the late stages of murine erythroid lineage.
    Br J Haematol. 2000 May;109(2):280-7 PMID: 10848813
  28. Tracking the response of natural killer T cells to a glycolipid antigen using CD1d tetramers.
    J Exp Med. 2000 Sep 4;192(5):741-54 PMID: 10974039
  29. The alphabeta T cell response to self-glycolipids shows a novel mechanism of CD1b loading and a requirement for complex oligosaccharides.
    Immunity. 2000 Aug;13(2):255-64 PMID: 10981968
  30. NK T cell-derived IL-10 is essential for the differentiation of antigen-specific T regulatory cells in systemic tolerance.
    J Immunol. 2001 Jan 1;166(1):42-50 PMID: 11123275
  31. A synthetic glycolipid prevents autoimmune encephalomyelitis by inducing TH2 bias of natural killer T cells.
    Nature. 2001 Oct 4;413(6855):531-4 PMID: 11586362
  32. A critical role for natural killer T cells in immunosurveillance of methylcholanthrene-induced sarcomas.
    J Exp Med. 2002 Jul 1;196(1):119-27 PMID: 12093876
  33. GD3, a prominent ganglioside of human melanoma. Detection and characterisation by mouse monoclonal antibody.
    J Exp Med. 1982 Apr 1;155(4):1133-47 PMID: 7061953
Article Info
Journal
The Journal of experimental medicine
Abbr.
J Exp Med
ISSN
0022-1007
Published
2003-07-07
Pages
173-81
Language
English
Region
United States
NLM ID
2985109R
PMCID
PMC2196074
Subset
IM
Grants
NCI NIH HHS · K24 CA081293 · United States
NCI NIH HHS · K24 CA81293 · United States
NCI NIH HHS · R01 CA2511 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com